Diseases

For several years we have approached a ‘standard of care’ (SOC) for the treatment of metastatic HER2-positive breast cancer....

The SGLT2 inhibitors, or gliflozins, have been rising stars in the fields of endocrinology and cardiology for their ability...

Dementia-like cognitive impairment has been reported in a significant number of COVID-19 patients and long hauler patients. However, the...

Researchers have discovered new therapeutic targets for acute myeloid leukemia (AML). A new study published in Stem Cells suggests...

The U.S Food and Drug Administration (FDA) has approved the first clinical trial of CRISPR to correct sickle cell...

Discovering treatments for Duchenne muscular dystrophy has been difficult because the disease is a result of a wide variety...

The human immune system makes antibodies that bind to the same antigen with both of their variable regions, or...

Chronic kidney disease (CKD), a global public issue is associated with substantial morbidity and mortality. In the past few...

An investigational therapy for Charcot-Marie-Tooth (CMT) disease is beginning its second Phase III trial. The therapy, called PXT3003, is...

Scientific developments typically require a good deal of time and money. Sadly, those two resources are not always in...